CYSLTR1 and malignant colon neoplasm: Previous studies have investigated the tumour-promoting effects of CysLT1R and have demonstrated its association with poor prognosis in CRC patients, as well as its tumour-promoting effects in colon cancer (CC) cell lines and several mouse models [19–21].